Skip to main content
. 2020 Jan 16;26(7):974–984. doi: 10.1093/ibd/izz328

TABLE 1.

Patient Characteristics of the 13 Patients with UC in Remission and 15 Patients with IBS-mixed and 15 Healthy Controls Included in the Study

UC IBS HCs
Age, median (range) 36 (21–72) years 31 (19–52) years 27 (21–61) years
Sex 7 women, 6 men 15 women 11 women, 4 men
Biopsy location Sigmoideum (n = 7) Sigmoideum (n = 15) Sigmoideum (n = 10)
Rectum (n = 6) Rectosigmoidal junction (n = 5)
Endoscopic Mayo score 0 (n = 12) 0 (n = 15) 0 (n = 15)
1 (n = 1)
Anti-inflammatory medication 5-ASA (n = 12) None None
Steroids (n = 1)
Infliximab (n = 1)
Azathioprine (n = 3)
Allergy/smoking Pollen (n = 2) None None
Pollen & fur (n = 1)
Smoking (n = 2)

Biopsies were taken in October-December that is outside pollen season in Sweden.

HHS Vulnerability Disclosure